We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mobile Device Rapidly Detects Zika and Related Viruses

By LabMedica International staff writers
Posted on 31 Mar 2017
A team of biologists and engineers have developed a smartphone-controlled, battery-operated, low-weight diagnostic technology that costs as little as USD 100 and can detect Zika, dengue, and chikungunya viruses within 30 minutes. More...
The same platform can also be adapted to detect other human or animal pathogens.

Accurate testing for these viruses currently requires a laboratory with expensive instruments, making local testing unrealistic for limited-resource clinics where the viruses are prevalent. The team, from Sandia National Laboratories (Livermore, CA, USA), used smartphone technology as a key feature: “In addition to creating an app that serves as a simple interface to operate the device, we were able to adapt smartphone camera sensors to replace traditional laboratory sample analysis tools, allowing for unprecedented mobility,” said lead author Aashish Priye.

The “laboratory in a box” device is based on the loop-mediated isothermal amplification (LAMP) diagnostic method, which eliminates PCR thermal cycling as well as the need to process the biological sample (e.g. blood or urine) before testing. LAMP copies viral DNA/RNA but without the heating/cooling cycles of PCR, so a heavy-duty power source is not needed. The addition of a few carefully designed biochemical reagents allows a LAMP box to test a sample that is heated only once for 30 minutes.

“We’ve demonstrated that the chemistry we’re using can amplify viral RNA directly from raw, unprocessed samples,” said project lead Robert Meagher, “That is the ideal for a point-of-care testing scenario because you don’t want to have extra equipment for isolating DNA or RNA.” Meagher and team previously developed a method to combine LAMP with an additional detection technique so that multiple viruses could be tested simultaneously. This other technique, named quenching of unincorporated amplification signal reporters (QUASR), involves using synthetic virus-based primers tagged with fluorophores for the sample-DNA/RNA amplification step.

For the Zika project, Meagher’s team developed a novel algorithm that allows a smartphone sensor to act as a fluorimeter, detecting QUASR LAMP light signals if they appear. The user need only place the smartphone on top of the LAMP box and open an app that turns on the heater to initiate the LAMP reaction, after which the smartphone photographs the sample. The app then employs a novel image analysis algorithm to determine the color and brightness of the fluorescence emitted from the LAMP reaction.

Zika, dengue, and chikungunya are spread via the same mosquito vector and have similar early symptoms. The team’s prototype diagnostic tool could enable care providers to test quickly for all three at the same time, preventing misdiagnoses.

The cost of making a LAMP box prototype to test for these viruses depends largely on the cost of the phone selected for using it with. “There are billions of smartphones in the world, even in developing countries, and this tool doesn’t require the highest-end smartphone on the market,” said Priye, “It only needs to have an optical sensor and be able to run the app.” The smartphone used in Sandia’s successful tests of the current prototype costs only USD 20.

The study, by Priye A et al, was published online March 20, 2017, in the journal Scientific Reports.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.